RecruitingNot ApplicableNCT07719608

A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine

Sponsor

Salvia BioElectronics

Enrollment

150 participants

Start Date

Dec 1, 2026

Study Type

INTERVENTIONAL

Conditions

Chronic Migraine, Headache Headache, Migraine Headache, Cluster Resistant Migraine

Summary

The purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine.

Eligibility

Min Age: 22 YearsMax Age: 84 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Neurostimulator for people with chronic migraine, headache, headache, cluster, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 84 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENeurostimulator

A neurostimulation system that consists of implantable and non-implantable components that work together to deliver mild electrical signals to targeted craniofacial nerves.